Codexis vs Tantech
CDXS and TANH side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CDXS and TANH compare
Codexis grew revenue faster over the last twelve months (35.9% versus −10.7% for Tantech).
Codexis keeps more of each dollar of sales as profit, with a net margin of −39.6% compared with −80.9% at Tantech.
Codexis scores higher on the StockData Score (4 against 1 for Tantech), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CDXS | TANH |
|---|---|---|
| Size and price | ||
| Market cap | $117M | – |
| Share price | $1.07 | $46.00 |
| Change, 1 year | −35.0% | −17.9% |
| Change, 5 years | −97.1% | −100.0% |
| Beta (5Y) | 2.46 | 4.01 |
| Employees | 146 | 45 |
| StockData Score | ||
| Total score | 4 (better) | 1 |
| Valuation score | 0 | 0 |
| Growth score | 2 (better) | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 1 | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.5× | – |
| P/B | 3.6× | – |
| FCF yield | −10.4% | – |
| Fair value | $1.07 | – |
| Margin of safety | −0.41% | – |
| Growth | ||
| Revenue growth (TTM) | 35.9% (better) | −10.7% |
| Revenue growth, 5Y average | 0.38% (better) | −1.9% |
| Profitability | ||
| Gross margin | 87.0% (better) | 18.6% |
| Operating margin | −35.6% | −31.8% (better) |
| Net margin | −39.6% (better) | −80.9% |
| FCF margin | −15.7% | −15.2% (better) |
| Return on equity | −69.4% | −25.7% (better) |
| Return on invested capital | −91.8% | −11.1% (better) |
| Financial health | ||
| Debt / equity | 1.24 | – |
| Interest coverage | – | −43.7× |
| Current ratio | 3.06 | 6.59 (better) |
| Altman Z-score | −6.14 | – |
| Piotroski F-score | 4 (better) | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 63.7% | – |
| Held by insiders | 2.2% | 0.02% |
| Insider net buying, 12 months | −$899K | – |
| Short interest, % of float | 4.1% | 0.57% |
Go deeper
- CDXS stock overview
- CDXS income statement
- CDXS valuation and score
- TANH stock overview
- TANH income statement
- TANH valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.